Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price

Market Focus06-10 10:15

On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.

On the news front, the company's cornerstone investors and employee restricted shares are set to exit their lock-up period on June 29, with approximately 453 million shares facing potential release — representing 81.25% of total share capital. Market concerns over concentrated selling pressure continue to intensify. The stock has declined nearly 40% over the past month, falling from its April highs.

Fundamentally, the company reported revenue of US$56.24 million for 2025, a year-over-year decline of 34.48%, with net loss attributable to shareholders reaching US$352 million. The current share price still carries a premium over its IPO price, meaning original shareholders remain in profit and have incentive to reduce holdings upon unlock.

Within the Life Sciences Tools and Services sector, the broader group also traded lower. WuXi Biologics fell 2.87%, GenScript Biotech declined 3.03%, and WuXi XDC dropped 3.14%, with sector-wide weakness further dampening sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1185699673?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 10:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185699673","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price","media":"Market Focus","content":"<p><p>On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.</p><p>On the news front, the company's cornerstone investors and employee restricted shares are set to exit their lock-up period on June 29, with approximately 453 million shares facing potential release — representing 81.25% of total share capital. Market concerns over concentrated selling pressure continue to intensify. The stock has declined nearly 40% over the past month, falling from its April highs.</p><p>Fundamentally, the company reported revenue of US$56.24 million for 2025, a year-over-year decline of 34.48%, with net loss attributable to shareholders reaching US$352 million. The current share price still carries a premium over its IPO price, meaning original shareholders remain in profit and have incentive to reduce holdings upon unlock.</p><p>Within the Life Sciences Tools and Services sector, the broader group also traded lower. WuXi Biologics fell 2.87%, GenScript Biotech declined 3.03%, and WuXi XDC dropped 3.14%, with sector-wide weakness further dampening sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-10 10:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.</p><p>On the news front, the company's cornerstone investors and employee restricted shares are set to exit their lock-up period on June 29, with approximately 453 million shares facing potential release — representing 81.25% of total share capital. Market concerns over concentrated selling pressure continue to intensify. The stock has declined nearly 40% over the past month, falling from its April highs.</p><p>Fundamentally, the company reported revenue of US$56.24 million for 2025, a year-over-year decline of 34.48%, with net loss attributable to shareholders reaching US$352 million. The current share price still carries a premium over its IPO price, meaning original shareholders remain in profit and have incentive to reduce holdings upon unlock.</p><p>Within the Life Sciences Tools and Services sector, the broader group also traded lower. WuXi Biologics fell 2.87%, GenScript Biotech declined 3.03%, and WuXi XDC dropped 3.14%, with sector-wide weakness further dampening sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1185699673","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185699673","pubTimestamp":1781057701,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.On the news front, the company's cornerstone investors and employee...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动静提示|英矽智能常规交易跌5.09%大规模禁售到期倒计时持续打压股价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.On the news front, the company's cornerstone investors and employee restricted shares are set to exit their lock-up period on June 29, with approximately 453 million shares facing potential release — representing 81.25% of total share capital. Market concerns over concentrated selling pressure continue to intensify. The stock has declined nearly 40% over the past month, falling from its April highs.Fundamentally, the company reported revenue of US$56.24 million for 2025, a year-over-year decline of 34.48%, with net loss attributable to shareholders reaching US$352 million. The current share price still carries a premium over its IPO price, meaning original shareholders remain in profit and have incentive to reduce holdings upon unlock.Within the Life Sciences Tools and Services sector, the broader group also traded lower. WuXi Biologics fell 2.87%, GenScript Biotech declined 3.03%, and WuXi XDC dropped 3.14%, with sector-wide weakness further dampening sentiment.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1185699673","isCrawlerRequest":true}